Pakizehkar, Safura
Research Institute for Endocrine Sciences
[ 1 ] - High-Density Lipoprotein Measurement Methods: From Precipitation to Nuclear Magnetic Resonance (NMR)
Introduction: Extensive research suggests a common hypothesis regarding the protective role of total high-density lipoprotein-cholesterol (HDL-C) against cardiovascular disease (CVD). This hypothesis indicates an inverse relationship between CVD and high HDL-C levels. Various mechanisms, such as reverse cholesterol transport, besides anti-inflammatory and antioxidant functions, indicate HDL-C a...
[ 2 ] - The measurement technologies of thyrotropin receptor antibodies from the past to the present
Thyroid Stimulating Hormone Receptor (TSH-R) autoantibodies are the main cause of Graveschr('39') disease and its external thyroid manifestations such as ophtalmopathy and dermatopathy. These antibodies are functionally different and are commonly called TSH receptor antibodies (TRAbs). In fact, TRAbs are a set of autoantibodies including TSHR-stimulating antibodies (TSAbs), TSHR- blocking antib...
[ 3 ] - The Role of miRNA Dysregulation in Thyroid Cancer Development by Targeting the Main Signaling Pathways
Thyroid cancer is one of the most common malignancies of endocrine glands, causing carcinomas, such as papillary, follicular, medullary, and anaplastic thyroid carcinomas. Due to the significance of thyroid carcinomas, identification of the main signaling pathways and the affecting mutations has been considered by researchers. Further studies on the dysregulation of oncogenes in signaling path...
[ 4 ] - RET proto-oncogene mutations in the diagnosis of medullary thyroid cancer: a review article
Medullary thyroid cancer accounts for 5-10% of thyroid carcinomas. RET proto-oncogene mutations occur in all of the hereditary MTCs and about 66% of the sporadic MTCs. So, the detection of the RET mutations is necessary for rapid and proper diagnosis and treatment. This systematic review seeks to find a comprehensive list of RET gene mutations in the diagnosis of medullary thyroid cancer. The ...
Co-Authors